The eight candidate genes—CD72, CHRDL2, DBI, HYAL1, IGFBP3, LRP11, SERPINH1, and SPARCL1—are involved in regulating the tumor immune microenvironment in CRC by modulating various immune cell types. This evidence concerns the gene DBI and neoplasm.